Literature DB >> 10951576

Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways.

J P Blaydes1, A L Craig, M Wallace, H M Ball, N J Traynor, N K Gibbs, T R Hupp.   

Abstract

High level activation of p53-dependent transcription occurs following cellular exposure to genotoxic damaging agents such as UV-C, while ionizing radiation damage does not induce a similarly potent induction of p53-dependent gene expression. Reasoning that one of the major differences between UV-C and ionizing radiation damage is that the latter does not inhibit general transcription, we attempted to reconstitute p53-dependent gene expression in ionizing irradiated cells by co-treatment with selected transcription inhibitors that alone do not activate p53. p53-dependent transcription can be dramatically enhanced by the treatment of ionizing irradiated cells with low doses of DRB, which on its own does not induce p53 activity. The mechanism of ionizing radiation-dependent activation of p53-dependent transcription using DRB is more likely due to inhibition of gene transcription rather than prolonged DNA damage, as the non-genotoxic and general transcription inhibitor Roscovitine also synergistically activates p53 function in ionizing irradiated cells. These results identify two distinct signal transduction pathways that cooperate to fully activate p53-dependent gene expression: one responding to lesions induced by ionizing radiation and the second being a kinase pathway that regulates general RNA Polymerase II activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10951576     DOI: 10.1038/sj.onc.1203773

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  7 in total

Review 1.  Strategies for manipulating the p53 pathway in the treatment of human cancer.

Authors:  T R Hupp; D P Lane; K L Ball
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

2.  CDK Inhibitors Roscovitine and CR8 Trigger Mcl-1 Down-Regulation and Apoptotic Cell Death in Neuroblastoma Cells.

Authors:  Karima Bettayeb; Dianne Baunbæk; Claire Delehouze; Nadège Loaëc; Alison J Hole; Sonja Baumli; Jane A Endicott; Setha Douc-Rasy; Jean Bénard; Nassima Oumata; Hervé Galons; Laurent Meijer
Journal:  Genes Cancer       Date:  2010-04

3.  Evaluation of cytotoxic activity of titanocene difluorides and determination of their mechanism of action in ovarian cancer cells.

Authors:  Lucie Koubkova; Rostislav Vyzula; Jindrich Karban; Jiri Pinkas; Eva Ondrouskova; Borivoj Vojtesek; Roman Hrstka
Journal:  Invest New Drugs       Date:  2015-07-24       Impact factor: 3.850

4.  Interruption of RNA processing machinery by a small compound, 1-[(4-chlorophenyl)methyl]-1H-indole-3-carboxaldehyde (oncrasin-1).

Authors:  Wei Guo; Shuhong Wu; Li Wang; Rui-yu Wang; Xiaoli Wei; Jinsong Liu; Bingliang Fang
Journal:  Mol Cancer Ther       Date:  2009-02-10       Impact factor: 6.261

5.  Differential p53 protein expression in breast cancer fine needle aspirates: the potential for in vivo monitoring.

Authors:  H M Ball; T R Hupp; D Ziyaie; C A Purdie; N M Kernohan; A M Thompson
Journal:  Br J Cancer       Date:  2001-10-19       Impact factor: 7.640

6.  Differential Effects of Cold Atmospheric Plasma in the Treatment of Malignant Glioma.

Authors:  Alan Siu; Olga Volotskova; Xiaoqian Cheng; Siri S Khalsa; Ka Bian; Ferid Murad; Michael Keidar; Jonathan H Sherman
Journal:  PLoS One       Date:  2015-06-17       Impact factor: 3.240

7.  CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells.

Authors:  Monika Štětková; Kateřina Growková; Petr Fojtík; Barbora Valčíková; Veronika Palušová; Amandine Verlande; Radek Jorda; Vladimír Kryštof; Václav Hejret; Panagiotis Alexiou; Vladimír Rotrekl; Stjepan Uldrijan
Journal:  Cell Death Dis       Date:  2020-09-15       Impact factor: 8.469

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.